As DEA Withdraws In Psychedelics Battle Over DOI And DOC, Researchers Win – For Now
The Drug Enforcement Administration (DEA) is pulling back efforts to list certain hallucinogens as Schedule I substances after being challenged by scientists. “DOI and DOC are incredible tools for research, as well as mental and physical health,” Panacea Plant Sciences CEO David Heldreth told Marijuana Moment. Heldreth was referring to dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC). […]
What Psychiatrists Think Of Current US Psychedelics Policies
Psychiatrists differ considerably in their perceptions of certain psychedelic substances. That’s according to a new report from Ohio State University, in which 181 doctors took part in a survey about psychedelic safety and therapeutic value, as well as how they are categorized under U.S. policy. These substances were originally classified in 1970, following the Controlled […]
Amazon Is Not Purchasing Electronic Arts, Faber Says: Gaming Stock Pops Premarket On M&A Rumors
Rumors that e-commerce behemoth Amazon.com Inc (NASDAQ: AMZN) was going to announce an offer to purchase the “Apex Legends” and “Madden NFL” maker Electronic Arts Inc. (NASDAQ: EA) began to circulate Friday morning. The report originated from the Swedish gaming media company Good Luck Have Fun and was shared by CNBC. The price of EA stock […]
Merck’s Buyout Of Seagen Hits Speed Braker Over Price Agreement: Report
Merck & Co Inc (NYSE: MRK) and Seagen Inc (NASDAQ: SGEN) have not been able to agree on a buyout price, Bloomberg reported. The deal talks have been stalled, for now, threatening Merck’s potentially the largest deal in more than a decade, according to people familiar with the matter. Previously, Merck and Seagen’s deal was expected to be sealed […]
Owl Creek Urges Cano Health Board To Consider Potential Sale
Owl Creek Asset Management L.P. sent a letter to Cano Health Inc (NYSE: CANO) board strongly encouraging the company to pursue strategic alternatives, including a potential sale. Owl Creek owns around a 3.75% stake in Cano. According to the letter, the asset management says, “the past year’s roller coaster of accounting issues has shaken our confidence. We feel that […]
Credit Suisse’s Largest Owner Asks For Sustainable Options For Troubled Investment Banking Unit
Bloomberg reported that Credit Suisse Group AG’s (NYSE: CS) largest shareholder had asked the firm to earn sustainable returns for its investment banking business or look for options, which has been the centerpiece of the losses over a couple of years. In an interview, David Herro, the chief investment officer of Harris Associates, said, “it can’t be fixed within […]
Elliott Management Started Buying Swedish Match Stock After Philip Morris $16B Bid – What’s Next
Philip Morris International Inc (NYSE: PM) may have to increase its Swedish Match AB’s (OTC: SWMAY) $16 billion bid to gain full ownership of the smokeless-tobacco maker, writes Wall Street Journal. Philip Morris wants to gain an edge over its competitors, including Altria Group Inc (NYSE: MO) and British American Tobacco PLC (NYSE: BTI), to dominate smoke-free tobacco products. According … Full story available on Benzinga.com […]
PetroChina Mulls Separate Listing For Its Energy Marketing Business: Report
PetroChina Company Limited (NYSE: PTR) is reportedly considering its marketing and trading business and seeking a separate listing. According to the annual report, the marketing division comprises refined products, including overseas, as well as crude oil, natural gas, and chemical products. It also includes some non-oil sales in PetroChina’s gas stations throughout the country, the report … Full […]
Optimi Health Given Green Light To Produce And Distribute MDMA In Canada, The Legal Landscape Ahead
Optimi Health Corp. (OTCQX: OPTHF) received permission from Health Canada to manufacture and distribute other psychedelic substances -most notably MDMA- under the amended terms outlined in its June 20, 2022 application to the institution. Optimi holds a license to produce natural psychedelic and functional mushrooms. The terms of the amendment became effective as of August 5, 2022. Production and […]
Is BioLife Sciences (OTCPK: BLFE) An OTC Company Primed For Growth?
HENDERSON, NV, Aug 10, 2022 – BioLife Sciences Inc. (BioLife), a commercialization accelerator, licensor and developer of technologies, has reportedly provided investors with a significant company update throughout the course of a two-year transformation. Over the course of the last two years, BioLife has gone through a number of changes evolving into a revamped corporate […]